Bénédicte Lebrun‐Vignes
Inserm(FR)Université Paris-Est Créteil(FR)Paris-Est Sup(FR)Sorbonne Université(FR)Assistance Publique – Hôpitaux de Paris(FR)Institut de Myologie(FR)Pitié-Salpêtrière Hospital(FR)Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale(FR)Epidemiology in dermatology and evaluation of therapeutics
Publications by Year
Research Areas
Drug-Induced Adverse Reactions, Pharmacovigilance and Adverse Drug Reactions, Autoimmune Bullous Skin Diseases, Urticaria and Related Conditions, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors(2018)2,518 cited
- → Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study(2018)1,149 cited
- → Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis(2018)881 cited
- Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms.(2001)
- → Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study(2019)348 cited
- → Cardiovascular Toxicities Associated With Ibrutinib(2019)253 cited
- → Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase